What is
.health?

John Brownstein, PhD, is the Chief Innovation Officer at Boston Children's Hospital. He is a global leader in HCIT and, in particular, the emerging fields of informatics and big data analytics. He runs a 50-person multi-disciplinary team focused on digital innovations that span clinicians and consumers. His group is supported by a multi-million dollar budget including grants from NIH, USAID, DoD, IARPA, CDC, Google, Skoll and Gates Foundation. His work has pioneered ‘digital epidemiology’- utilizing diverse digital data sources to understand population health. His work is published in over 150 peer-reviewed papers, all focused on new methods and applications in digital health. This work was recognized by the White House with the Presidential Early Career Award for Scientists and Engineers.

He also leads the development of several novel patient facing public health systems, including HealthMap, Vaccine Finder and MedWatcher. The systems are considered premier global public health tools in use by millions of patients each year and endorsed by numerous public health agencies including CDC, WHO, DHS, DOD, HHS, and EU, and has been recognized by the National Library of Congress and the Smithsonian. In addition to research achievements, this translational impact comes from playing an advisory role to numerous agencies on real-time public health surveillance including HHS, DHS, CDC, IOM, WHO and the White House.

Dr. Brownstein is a successful entrepreneur having developed new technologies, started multiple companies and outlicensed technologies. John has extensive experience establishing industry/academic partnerships, including work with Google, Twitter and Uber. As a long time (11 years) BCH employee, he is familiar with BCH and the many talented doctors, nurses and scientists here who serve as the core of Boston Children’s innovation engine.

John sets LegitScript’s overall strategy and oversees its execution. He founded LegitScript in 2007, after working for five years as a drug policy advisor in the White House, where he helped the Drug Czar coordinate national policy on prescription drug abuse, methamphetamine and chemical diversion. He previously worked as a prosecutor and legal counsel to the Oregon House Judiciary Committee. John lived for several years in Tokyo, where he worked in the finance industry and pursued a Master’s degree in International Law.

With over 20 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine Track for Singularity University since its inception. He is the founder and Executive Director of Exponential Medicine since 2011, a conference that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.

He has multiple patents on medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California, San Francisco.

Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. Clinical work focuses on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. He also implemented the first text-paging system at Stanford Hospital.

Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data driven, and integrated personalized health & medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies.

Dori Salcido is a trusted advisor for presidents, C-suite executives, senior government officials, and start-up entrepreneurs. For more than 20 years, Salcido has served as a strategist and project manager for clients in the federal and private sector. As the founder of Salcido Strategies, she provides critical counsel and support to agencies, organizations, and individuals that are looking to advance their market position, increase engagement, and achieve measurable results. She has established expertise in crisis communications, political campaigns, the federal government, healthcare, and technology.

As Assistant Secretary for Public Affairs at the U.S. Department of Health and Human Services (HHS) during the Obama administration, she planned and implemented the largest public education campaign in agency history on the benefits of the Affordable Care Act. During her HHS tenure, Salcido also served as the Deputy Assistant Secretary for Public Affairs and began her HHS service as the Communications Director for the Assistant Secretary for Health and the Surgeon General.

Salcido’s federal agency success was preceded by nearly a decade of experience in the private sector.

As Senior Communications Director for AOL, she led the company's public relations and executed media strategies and marketing campaigns to support AOL's international expansion efforts in Europe, Asia-Pacific, South America and Latin America.

Earlier in her career, Salcido served as a Special Assistant and Director of Media Operations to President Clinton in the White House Press Office. Salcido earned her Bachelor of Arts degree in Political Science and Speech Communications from the University of New Mexico, Albuquerque. She lives in Alexandria, Virginia.

Nicolai was the Co-Founder and COO of .CO, the administrator of the .CO domain, which was acquired in 2014 by Neustar. Under his tenure, .CO had incredible growth and became one of the most successful domain extensions in history, with more than 2.2 million domain names registered by people in 200 countries. Since joining Neustar in 2014 Nicolai has lead their strategic initiatives growing the Domain business organically and through M&A. More recently he became the General Manager of their Security Solutions division, which provides Fortune 500 companies solutions to monitor, accelerate and defend their online presence.

Apart from .CO and Neustar, Nicolai has more than 20 years of experience in technology, operations and project management. Originally from Colombia, Nicolai was previously a Director at Citigroup’s Investment Bank in New York overseeing a large team in New York, London, São Paulo, and Mumbai. Prior to that Nicolai worked in various consulting firms providing advisory services to global firms in the US and Latin-America.

Nicolai holds a degree in Industrial Engineering (honors) from the University of Miami, as well as an MBA from Columbia University and London Business School.

Over the last few years Nicolai has become involved in the startup community globally and is an active mentor at Ashoka, Endeavor and a few other entities. Plus he is an active investor in startups through different groups including Accelerated Growth Partners.